• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM RED72 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM RED72 REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number RED72KIT
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/26/2023
Type of Reportable Event Malfunction
Event or Problem Description
The patient was undergoing a thrombectomy procedure in the right carotid artery and middle cerebral artery (mca) using a penumbra system red72 reperfusion catheter (red72), a benchmark bmx96 access system (bmx96), a neuron max 6f 088 long sheath (neuron max), and a non-penumbra microcatheter.During the procedure, the physician made one pass in the target vessel using the red72.After the pass, the physician noticed there was clot inside of the red72 and decided to remove the red72 for flushing.While removing the red72, the physician noticed majority of the red72 was being pulled out from the sheath.The physician performed a fluoroscopy and noticed the red72 appeared to be fractured in the vessel.The proximal red72 was removed with the bmx96.The physician then placed a neuron max and snared the distal red72.The procedure was completed using a new non-penumbra aspiration catheter and a non-penumbra guide catheter.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
The device has been returned and the investigation results are pending.A follow up mdr will be submitted upon completion of the device investigation.H3 other text : placeholder.
 
Additional Manufacturer Narrative
Evaluation of the returned red72 confirmed that the catheter was fractured and revealed that the catheter was stretched at the fractured location.This damage typically occurs due to retraction against resistance.Further evaluation revealed multiple kinks on both proximal and distal fracture segments.This damage may have also occurred during manipulation.The kink on the distal fracture portion of the red72 near the fracture location likely occurred while snaring.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM RED72 REPERFUSION CATHETER
Common Device Name
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key17577646
Report Number3005168196-2023-00395
Device Sequence Number8349229
Product Code NRY
UDI-Device Identifier00815948023932
UDI-Public815948023932
Combination Product (Y/N)N
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
K211654
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/12/2023
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/03/2025
Device Catalogue NumberRED72KIT
Device Lot NumberH12725
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/11/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/26/2023
Supplement Date Received by Manufacturer08/17/2023
Initial Report FDA Received Date08/18/2023
Supplement Report FDA Received Date09/12/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/04/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age74 YR
Patient SexMale
Date Report Sent to FDA01/01/2005
-
-